10/27/2023
There have been other recent recalls issued for OTC medicines.
This isn't the only time recently that OTC medicines have been pulled from shelves over safety concerns. On May 18, the U.S. Consumer Product Safety Commission (CPSC) announced that Acme United had recalled four of its PhysiciansCare brand allergy and cold medications. In this case, the company said the products weren't sold in child-resistant packaging, "posing a risk of poisoning if the contents are swallowed by young children."
Another recall was issued for seven different OTC Advil products sold at Family Dollar earlier this month. In a May 4 notice, the FDA said that 73 batches of the medicine were pulled from shelves after the retailer had stored the items "outside of labeled temperature requirements." Customers were advised to return the affected products to their store of purchase for a full refund.
And on April 26, the FDA announced that Illinois-based Akorn Operating Company LLC had issued a voluntary recall for over 80 of its medicinal products, including OTC meds, prescription drugs, and pet medical products. The manufacturer pulled the items from the market—which included common products such as artificial tears, lidocaine ointment, and vitamin D drops—just over two months after it filed for Chapter 7 bankruptcy and terminated all its employees at its domestic U.S. production sites.
The company said that without its in-house quality assurance program in place, it would no longer be able to support or guarantee that the items will meet specifications through the rest of their shelf life. As a result, customers were advised to throw away any of the affected products and to contact their healthcare provider.